Are primary cultures realistic models of prostate cancer?

Journal of Cellular Biochemistry

Volumn 91, Issue 1, 2004, Pages 185-195

  Peehl, Donna M ^a,b  

^a STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b STANFORD UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

Cell culture; Epithelium; Prostate cancer

Indexed keywords

ADENOCARCINOMA; CANCER CELL CULTURE; HUMAN; IN VITRO STUDY; PRIORITY JOURNAL; PROSTATE CANCER; REVIEW; TUMOR MODEL; ANIMAL; CELL AGING; CELL LINE; CHROMOSOME ABERRATION; CYTOLOGY; EPITHELIUM CELL; GENETICS; MALE; PATHOLOGY; PHYSIOLOGY; PROSTATE TUMOR;

KERATIN;

ANIMALS; CELL AGING; CELL LINE, TRANSFORMED; CHROMOSOME ABERRATIONS; EPITHELIAL CELLS; HUMANS; KERATINS; MALE; PROSTATIC NEOPLASMS;

EID: 3242743135     PISSN: 07302312     EISSN: 10974644     Source Type: Journal    
DOI: 10.1002/jcb.10691     Document Type: Review

References (92)

1. Arps S, Rodewald A, Schmalenberger B, Carl P, Bressel M, Kastendieck H. 1993. Cytogenetic survey of 32 cancers of the prostate. Cancer Genet Cytogenet 66:93-99.
2. Barreto AM, Schwartz GG, Woodruff R, Cramer SD. 2000. 25-Hydroxyvitamin D3, the prohormone of 1,25-dihydroxyvitamin D3, inhibits the proliferation of primary prostatic epithelial cells. Cancer Epidemiol Biomarkers Prev 9:265-270.
3. Bonkhoff H, Stein U, Remherger K. 1994. Multidirectional differentiation in the normal, hyperplastic, and neoplastic human prostate: Simultaneous demonstration of cell-specific epithelial markers. Hum Pathol 25:42-46.
4. Brawer MK, Peehl DM, Stamey TA, Bostwick DG. 1985. Keratin immunoreactivity in the benign and neoplastic human prostate. Cancer Res 45:3663-3667.
5. Brawer MK, Bostwick DG, Peehl DM, Stamey TA. 1986. Keratin protein in human prostatic tissue and cell culture. Ann NY Acad Sci 455:729-731.
6. Brothman AR, Peehl DM, Patel AM, McNeal JE. 1990. Frequency and pattern of karyotypic abnormalities in human prostate cancer. Cancer Res 50:3795-3803.
7. Brothman AR, Peehl DM, Patel AM, MacDonald GR, McNeal JE, Ladaga LE, Schellhammer PF. 1991. Cytogenetic evaluation of 20 cultured primary prostatic tumors. Cancer Genet Cytogenet 55:79-84.
8. Brothman AR, Patel AM, Peehl DM, Schellhammer PF. 1992. Analysis of prostatic tumor cultures using fluorescence in-situ hybridization (FISH). Cancer Genet Cytogenet 62:180-185.
9. Brothman AR, Maxwell TM, Cui J, Deubler DA, Zhu XL. 1999. Chromosomal clues to the development of prostate tumors. Prostate 38:303-312.
10. Campbell CL, Savarese DM, Quesenberry PJ, Savarese TM. 1999. Expression of multiple angiogenic cytokines in cultured normal human prostate epithelial cells: Predominance of vascular endothelial growth factor. Int J Cancer 80:868-874.
11. Chatterjee S, Brite KH, Matsumura A. 2001. Induction of apoptosis of integrin-expressing human prostate cancer cells by cyclic Arg-Gly-Asp peptides. Clin Cancer Res 7:3006-3011.
12. Chen TC, Schwartz GG, Burnstein KL, Lokeshwar BL, Holick MF. 2000. The in vitro evaluation of 25-hydroxyvitamin D3 and 19-nor-1alpha,25-dihydroxyvitamin D2 as therapeutic agents for prostate cancer. Clin Cancer Res 6:901-908.
13. Chopra DP, Grignon DJ, Joiakim A, Mathieu PA, Mohamed A, Sakr WA, Powell IJ, Sarkar FH. 1996. Differential growth factor responses of epithelial cell cultures derived from normal human prostate, benign prostatic hyperplasia, and primary prostate carcinoma. J Cell Physiol 169: 269-280.
14. Chopra DP, Sarkar FH, Grignon DJ, Sakr WA, Mohamed A, Waghray A. 1997. Growth of human nondiploid primary prostate tumor epithelial cells in vitro. Cancer Res 57:3688-3692.
15. Coffey RN, Watson RW, Hegarty PK, Watson CL, Wolohan L, Brady HR, O'Keane C, Fitzpatrick JM. 2001. Priming prostate carcinoma cells for increased apoptosis is associated with up-regulation of the caspases. Cancer 92: 2297-2308.
16. Cramer SD, Peehl DM, Edgar MG, Wong ST, Deftos LJ, Feldman D. 1996. Parathyroid hormone-related protein (PTHrP) is an epidermal growth factor-regulated secretory product of human prostatic epithelial cells. Prostate 29:20-29.
17. Cussenot O, Berthon P, Cochand-Priollet B, Maitland NJ, Le Due A. 1994. Immunocytochemical comparison of cultured normal epithelial prostatic cells with prostatic tissue sections. Exp Cell Res 214:83-92.
18. Doll JA, Reiher FK, Crawford SE, Pins MR, Campbell SC, Bouck NP. 2001. Thrombospondin-1, vascular endothelial growth factor and fibroblast growth factor-2 are key functional regulators of angiogenesis in the prostate. Prostate 49:293-305.
19. Garraway LA, Lin D, Signoretti S, Waltregny D, Dilks J, Bhattacharya N, Loda M. 2003. Intermediate basal cells of the prostate: In vitro and in vivo characterization. Prostate 55:206-218.
20. Giri D, Ozen M, Ittmann M. 2001. Interleukin-6 is an autocrine growth factor in human prostate cancer. Am J Pathol 159:2159-2165.
21. Goossens K, Deboel L, Swinnen JV, Roskams T, Manin M, Rombauts W, Verhoeven G. 2002. Both retinoids and androgens are required to maintain or promote functional differentiation in reaggregation cultures of human prostate epithelial cells. Prostate 53: 34-49.
22. Guo X, Knudsen BS, Peehl DM, Ruiz A, Bok D, Rando RR, Rhim JS, Nanus DM, Gudas LJ. 2002. Retinol metabolism and lecithin: Retinol acyltransferase (LRAT) levels are reduced in cultured human prostate cancer cells and tissue specimens. Cancer Res 62:1654-1661.
23. Hall JA, Maitland NJ, Stower M, Lang SH. 2002. Primary prostate stromal cells modulate the morphology and migration of primary prostate epithelial cells in type 1 collagen gels. Cancer Res 62:58-62.
24. Hart CA, Scott LJ, Bagley S, Bryden AA, Clarke NW, Lang SH. 2002. Role of proteolytic enzymes in human prostate bone metastasis formation: In vivo and in vitro studies. Br J Cancer 86:1136-1142.
25. Hayward SW, Wang Y, Cao M, Hom YK, Zhang B, Grossfeld GD, Sudilovsky D, Cunha GR. 2001. Malignant transformation in a nontumorigenic human prostatic epithelial cell line. Cancer Res 61:8135-8142.
26. He X-Y, Yang Y-Z, Peehl DM, Lauderdale A, Schulz H, Yang S-Y. 2003. Oxidative 3α-hydroxysteroid dehydrogenase activity of human type 10 17β-hydrozysteroid dehydrogenase. J St Biochem Mol Biol (in press).
27. Hsu JY, Feldman D, McNeal JE, Peehl DM. 2001. Reduced 1alpha-hydroxylase activity in human prostate cancer cells correlates with decreased susceptibility to 25-hydroxyvitamin D3-induced growth inhibition. Cancer Res 61:2852-2856.
28. Iype PT, Iype LE, Verma M, Kaighn ME. 1998. Establishment and characterization of immortalized human cell lines from prostatic carcinoma and benign prostatic hyperplasia. Int J Oncol 12:257-263.
29. Jack GS, Brash AR, Olson SJ, Manning S, Coffey CS, Smith JA, Jr., Shappell SB. 2000. Reduced 15-lipoxygenase-2 immunostaining in prostate adenocarcinoma: Correlation with grade and expression in high-grade prostatic intraepithelial neoplasia. Hum Pathol 31:1146-1154.
30. Jones E, Zhu XL, Rohr LR, Stephenson RA, Brothman AR. 1994. Aneusomy of chromosomes 7 and 17 detected by FISH in prostate cancer and the effects of selection in vitro. Genes Chromosomes Cancer 11:163-170.
31. Kallakury BV, Sheehan CE, Ross JS. 2001. Co-downregulation of cell adhesion proteins alpha- and beta-catenins, p120CTN, E-cadherin, and CD44 in prostatic adenocarcinomas. Hum Pathol 32:849-855.
32. Ketter R, Zwergel T, Romanakis K, Unteregger G, Ziegler M, Zang KD, Wullich B. 1996. Selection toward diploid cells in prostatic carcinoma derived cell cultures. Prostate 28:364-371.
33. Kiviharju TM, Lecane PS, Sellers RG, Peehl DM. 2002. Antiproliferative and proapoptotic activities of triptolide (PG490), a natural product entering clinical trials, on primary cultures of human prostatic epithelial cells. Clin Cancer Res 8:2666-2674.
34. Knapp AC, Franke WW. 1989. Spontaneous losses of control of cytokeratin gene expression in transformed, non-epithelial human cells occurring at different levels of regulation. Cell 59:67-79.
35. Konig JJ, Teubel W, van Dongen JW, Hagemeijer A, Romijn JC, Schroder FH. 1993a. Tissue culture loss of aneuploid cells from carcinomas of the prostate. Genes Chromosomes Cancer 8:22-27.
36. Konig JJ, van Dongen JW, Schroder FH. 1993b. Preferential loss of abnormal prostate carcinoma cells by collagenase treatment. Cytometry 14:805-810.
37. Konig JJ, Teubel W, Kamst E, Romijn JC, Schroder FH, Hagemeijer A. 1998. Cytogenetic analysis of 39 prostate carcinomas and evaluation of short-term tissue culture techniques. Cancer Genet Cytogenet 101:116-122.
38. Kothari MS, Ali S, Buluwela L, Livni N, Shousha S, Sinnett HD, Vashisht R, Thorpe P, Van Noorden S, Coombes RC, Slade MJ. 2003. Purified malignant mammary epithelial cells maintain hormone responsiveness in culture. Br J Cancer 88:1071-1076.
39. Krege JH, Hodgin JB, Couse JF, Enmark E, Warner M, Mahler JF, Sar M, Korach KS, Gustafsson JA, Smithies O. 1998. Generation and reproductive phenotypes of mice lacking estrogen receptor beta. Proc Natl Acad Sci USA 95:15677-15682.
40. Lang SH, Clarke NW, George NJ, Allen TD, Testa NG. 1998. Interaction of prostate epithelial cells from benign and malignant tumor tissue with bone-marrow stroma. Prostate 34:203-213.
41. Lau KM, LaSpina M, Long J, Ho SM. 2000. Expression of estrogen receptor (ER)-alpha and ER-beta in normal and malignant prostatic epithelial cells: Regulation by methylation and involvement in growth regulation. Cancer Res 60:3175-3182.
42. Leav I, McNeal JE, Kwan PW, Komminoth P, Merk FB. 1996. Androgen receptor expression in prostatic dysplasia (prostatic intraepithelial neoplasia) in the human prostate: An immunohistochemical and in situ hybridization study. Prostate 29:137-145.
43. Leav I, Lau KM, Adams JY, McNeal JE, Taplin ME, Wang J, Singh H, Ho SM. 2001. Comparative studies of the estrogen receptors beta and alpha and the androgen receptor in normal human prostate glands, dysplasia, and in primary and metastatic carcinoma. Am J Pathol 159:79-92.
44. Lewis KC, Hochadel JF. 1999. Retinoid metabolism in the prostate: Effects of administration of the synthetic retinoid N-(4-hydroxyphenyl)retinamide. Cancer Res 59:5947-5955.
45. Limon J, Lundgren R, Elfving P, Heim S, Kristoffersson U, Mandahl N, Mitelman F. 1990. An improved technique for short-term culturing of human prostatic adenocarcinoma tissue for cytogenetic analysis. Cancer Genet Cytogenet 46:191-199.
46. Lin XS, Denmeade SR, Cisek L, Isaacs JT. 1997. Mechanism and role of growth arrest in programmed (apoptotic) death of prostatic cancer cells induced by thapsigargin. Prostate 33:201-207.
47. Litvinov IV, De Marzo AM, Isaacs JT. 2003. Is the Achilles' heel for prostate cancer therapy a gain of function in androgen receptor signaling? J Clin Endocrinol Metab 88:2972-2982.
48. Liu AY, Peehl DM. 2001. Characterization of cultured human prostatic epithelial cells by cluster designation antigen expression. Cell Tissue Res 305:389-397.
49. Lokeshwar VB, Rubinowicz D, Schroeder GL, Forgacs E, Minna JD, Block NL, Nadji M, Lokeshwar BL. 2001. Stromal and epithelial expression of tumor markers hyaluronic acid and HYAL1 hyaluronidase in prostate cancer. J Biol Chem 276:11922-11932.
50. Micale MA, Mohamed A, Sakr W, Powell IJ, Wolman SR. 1992. Cytogenetics of primary prostatic adenocarcinoma. Clonality and chromosome instability. Cancer Genet Cytogenet 61:165-173.
51. Nunn SE, Peehl DM, Cohen P. 1997. Acid-activated insulin-like growth factor binding protein protease activity of cathepsin D in normal and malignant prostatic epithelial cells and seminal plasma. J Cell Physiol 171:196-204.
52. Pasquali D, Thaller C, Eichele G. 1996. Abnormal level of retinoic acid in prostate cancer tissues. J Clin Endocrinol Metab 81:2186-2191.
53. Pasquali D, Rossi V, Esposito D, Abbondanza C, Puca GA, Bellastella A, Sinisi AA. 2001. Loss of estrogen receptor beta expression in malignant human prostate cells in primary cultures and in prostate cancer tissues. J Clin Endocrinol Metab 86:2051-2055.
54. Peehl DM. 1985. Serial culture of adult human prostatic epithelial cells. J Tissue Culture Methods 9:53-60.
55. Peehl DM. 1992. Culture of human prostatic epithelial cells. In: Freshney RI, editor. Culture of epithelial cells. New York, NY: Wiley-Liss, Inc. pp 159-180.
56. Peehl DM, Sellers RG. 2002. Epithelial cell culture: Prostate. In: Atala A, Lanza R, editors. Methods of tissue engineering. San Diego: Academic Press. pp 247-261.
57. Peehl DM, Stamey TA. 1986a. Growth responses of normal, benign hyperplastic, and malignant human prostatic epithelial cells in vitro to cholera toxin, pituitary extract, and hydrocortisone. Prostate 8:51-61.
58. Peehl DM, Stamey TA. 1986b. Serum-free growth of adult human prostatic epithelial cells. In Vitro Cell Dev Biol 22:82-90.
59. Peehl DM, Wong ST, Stamey TA. 1988. Clonal growth characteristics of adult human prostatic epithelial cells. In Vitro Cell Dev Biol 24:530-536.
60. Peehl DM, Wong ST, Bazinet M, Stamey TA. 1989. In vitro studies of human prostatic epithelial cells: Attempts to identify distinguishing features of malignant cells. Growth Factors 1:237-250.
61. Peehl DM, Wong ST, Stamey TA. 1991a. Cytostatic effects of suramin on prostate cancer cells cultured from primary tumors. J Urol 145:624-630.
62. Peehl DM, Wong ST, Terris MK, Stamey TA. 1991b. Culture of prostatic epithelial cells from ultrasound-guided needle biopsies. Prostate 19:141-147.
63. Peehl DM, Wong ST, Stamey TA. 1993. Vitamin A regulates proliferation and differentiation of human prostatic epithelial cells. Prostate 23:69-78.
64. Peehl DM, Leung GK, Wong ST. 1994a. Keratin expression: A measure of phenotypic modulation of human prostatic epithelial cells by growth inhibitory factors. Cell Tissue Res 277:11-18.
65. Peehl DM, Skowronski RJ, Leung GK, Wong ST, Stamey TA, Feldman D. 1994b. Antiproliferative effects of 1,25-dihydroxyvitamin D3 on primary cultures of human prostatic cells. Cancer Res 54:805-810.
66. Peehl DM, Sellers RG, McNeal JE. 1996a. Keratin 19 in the adult human prostate: Tissue and cell culture studies. Cell Tissue Res 285:171-176.
67. Peehl DM, Wong ST, Rubin JS. 1996b. KGF and EGF differentially regulate the phenotype of prostatic epithelial cells. Growth Regul 6:22-31.
68. Rayford W, Noble MJ, Austenfeld MA, Weigel J, Mebust WK, Shah GV. 1997. Muscarinic cholinergic receptors promote growth of human prostate cancer cells. Prostate 30:160-166.
69. Rizner TL, Lin HK, Peehl DM, Steckelbroeck S, Bauman DR, Penning TM. 2003. Human type 3 3alpha-hydroxysteroid dehydrogenase (aldo-keto reductase 1C2) and androgen metabolism in prostate cells. Endocrinology 144:2922-2932.
70. Sandhu C, Peehl DM, Slingerland J. 2000. p16INK4A mediates cyclin dependent kinase 4 and 6 inhibition in senescent prostatic epithelial cells. Cancer Res 60:2616-2622.
71. Schmid HP, McNeal JE. 1992. An abbreviated standard procedure for accurate tumor volume estimation in prostate cancer. Am J Surg Pathol 16:184-191.
72. 3. Cancer Epidemiol Biomark Prev 7:391-395.
73. Schwarze SR, Shi Y, Fu VX, Watson PA, Jarrard DF. 2001. Role of cyclin-dependent kinase inhibitors in the growth arrest at senescence in human prostate epithelial and uroepithelial cells. Oncogene 20:8184-8192.
74. Shappell SB, Boeglin WE, Olson SJ, Kasper S, Brash AR. 1999. 15-Lipoxygenase-2 (15-LOX-2) is expressed in benign prostatic epithelium and reduced in prostate adenocarcinoma. Am J Pathol 155:235-245.
75. Signoretti S, Loda M. 2001. Estrogen receptor beta in prostate cancer: Brake pedal or accelerator? Am J Pathol 159:13-16.
76. Stearns ME, Ware JL, Agus DB, Chang CJ, Fidler IJ, Fife RS, Goode R, Holmes E, Kinch MS, Peehl DM, Pretlow TG II, Thalmann GN. 1998. Workgroup 2: Human xenograft models of prostate cancer. Prostate 36:56-58.
77. Szucs S, Zitzelsberger H, Breul J, Bauchinger M, Hofler H. 1994. Two-phase short-term culture method for cytogenetic investigations from human prostate carcinoma. Prostate 25:225-235.
78. Tang DG, Li L, Chopra DP, Porter AT. 1998. Extended survivability of prostate cancer, cells in the absence of trophic factors: Increased proliferation, evasion of apoptosis, and the role of apoptosis proteins. Cancer Res 58:3466-3479.
79. Tang S, Bhatia B, Maldonado CJ, Yang P, Newman RA, Liu J, Chandra D, Traag J, Klein RD, Fischer SM, Chopra D, Shen J, Zhau HE, Chung LW, Tang DG. 2002. Evidence that arachidonate 15-lipoxygenase 2 is a negative cell cycle regulator in normal prostate epithelial cells. J Biol Chem 277:16189-16201.
80. Torring N, Sorensen BS, Bosch ST, Klocker H, Nexo E. 1998. Amphiregulin is expressed in primary cultures of prostate, myofibroblasts, fibroblasts, epithelial cells, and in prostate tissue. Prostate Cancer Pros Dis 5:262-267.
81. Tran CP, Lin C, Yamashiro J, Reiter RE. 2002. Prostate stem cell antigen is a marker of late intermediate prostate epithelial cells. Mol Cancer Res 1:113-121.
82. van Bokhoven A, Varella-Garcia M, Korch C, Hessels D, Miller GJ. 2001. Widely used prostate carcinoma cell lines share common origins. Prostate 47:36-51.
83. van Leenders G, Dijkman H, Hulsbergen-van de Kaa C, Ruiter D, Schalken J. 2000. Demonstration of intermediate cells during human prostate epithelial differentiation in situ and in vitro using triple-staining confocal scanning microscopy. Lab Invest 80:1251-1258.
84. Wallen E, Sellers RG, Peehl DM. 2000. Brefeldin A induces p53-independent apoptosis in primary cultures of human prostatic cancer cells. J Urol 164:836-841.
85. Wang J, Torbenson M, Wang Q, Ro JY, Becich M. 2003. Expression of inducible nitric oxide synthase in paired neoplastic and non-neoplastic primary prostate cell cultures and prostatectomy specimen. Urol Oncol 21: 117-122.
86. Webb HD, Hawkins AL, Griffin CA. 1996. Cytogenetic abnormalities are frequent in uncultured prostate cancer cells. Cancer Genet Cytogenet 88:126-132.
87. Whitlatch LW, Young MV, Schwartz GG, Flanagan JN, Burnstein KL, Lokeshwar BL, Rich ES, Holick MF, Chen TC. 2002. 25-Hydroxyvitamin D-1alpha-hydroxylase activity is diminished in human prostate cancer cells and is enhanced by gene transfer. J Steroid Biochem Mol Biol 81:135-140.
88. Wilson MJ, Sellers RG, Wiehr C, Melamud O, Pei D, Peehl DM. 2002. Expression of matrix metalloproteinase-2 and -9 and their inhibitors, tissue inhibitor of metalloproteinase-1 and -2, in primary cultures of human prostatic stromal and epithelial cells. J Cell Physiol 191:208-216.
89. Xu Y, Iyengar S, Roberts RL, Shappell SB, Peehl DM. 2003. Primary culture model of peroxisome proliferator-activated receptor gamma activity in prostate cancer cells. J Cell Physiol 196:131-143.
90. Zajchowski D, Band V, Pauzie N, Tager A, Stampfer M, Sager R. 1988. Expression of growth factors and oncogenes in normal and tumor-derived human mammary epithelial cells. Cancer Res 48:7041-7047.
91. Zheng DQ, Woodard AS, Fornaro M, Tallini G, Languino LR. 1999. Prostatic carcinoma cell migration via alpha(v)beta3 integrin is modulated by a focal adhesion kinase pathway. Cancer Res 59:1655-1664.
92. Zwergel T, Kakirman H, Schorr H, Wullich B, Unteregger G. 1998. A new serial transfer explant cell culture system for human prostatic cancer tissues preventing selection toward diploid cells. Cancer Genet Cytogenet 101:16-23.